409410005: Bevacizumab 25mg/mL injection solution 16mL vial (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2464861013 Bevacizumab 25mg/mL injection solution 16mL vial (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

2471196011 Bevacizumab 25mg/mL injection solution 16mL vial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

2477419015 Bevacizumab 400mg/16mL injection solution en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

2477420014 Bevacizumab 400mg injection en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

2553470018 Bevacizumab 400mg/16mL concentrate for solution for infusion en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3600501000005116 bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 16 ml da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 16 ml	Is a	Product containing bevacizumab (medicinal product)	false	Inferred relationship	Some
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 16 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Bevacizumab (substance)	false	Inferred relationship	Some
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 16 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Monoclonal antibody	false	Inferred relationship	Some
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 16 ml	Has manufactured dose form	injektionsvæske	false	Inferred relationship	Some
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 16 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Immunosuppressant (substance)	false	Inferred relationship	Some
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 16 ml	Is a	Product manufactured as parenteral dose form (product)	false	Inferred relationship	Some
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 16 ml	Has manufactured dose form	Solution for injection	false	Inferred relationship	Some
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 16 ml	Is a	Product containing bevacizumab in parenteral dose form (medicinal product form)	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Concept inactivation indicator reference set

POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)